ICP monitoring is an important parameter in the diagnosis, management, and follow-up of patients with neurological conditions such as traumatic brain injury (TBI) stroke and brain surgeries.
The market potential for ICP monitoring is much larger than the current market size. From the current 4.5 million annual potential procedures in the U.S.
only around 200,000 invasive ICP monitoring procedures are performed. The small number of procedures derives from the invasive nature of the current gold- standard, and due to the fact that some patients are unable to undergo the procedure.
The current non-invasive methods for ICP monitoring that are available today are not accurate enough for routine use and most of them did not reach commercial stage, which leads to a real need for a non-invasive accurate and continuous method to monitor ICP.